Chase Therapeutics' Series A Round

Chase Therapeutics raised a round of funding on November 22, 2017. Investors include Brain Trust Accelerator Fund.

Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease.…

Articles about Chase Therapeutics' Series A Round: